Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated malaria in children in Bengo Province, Angola
ISRCTN78910521Phase 4Completed
- Sponsor
- Hospital Pediátrico David Bernardino
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether and lumefantrine in Malaria, sponsored by Hospital Pediátrico David Bernardino. Primary endpoint: PCR-corrected recrudescent infections by day 28. Started Dec 2020; status: completed.
02
Drugs
artemetherlumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN78910521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN78910521.